4.6 Article

Current progress in CRISPR-based diagnostic platforms

Journal

JOURNAL OF CELLULAR BIOCHEMISTRY
Volume 120, Issue 3, Pages 2721-2725

Publisher

WILEY
DOI: 10.1002/jcb.27690

Keywords

attomolar; Cas13a; clustered regularly interspaced short palindromic repeats-based diagnostic; epidemic diseases; guide-RNA; multiplex

Funding

  1. Puri Foundation for Education in India

Ask authors/readers for more resources

The CRISPR-Cas system is a key technology for genome editing and regulation in a wide range of organisms and cell types. Recently, CRISPR-Cas-based diagnostic platform has shown idealistic properties for pathogen detection. Integrating the CRISPR-Cas platform along with lateral flow system allows rapid, sensitive, specific, cheap, and reliable diagnostic. It has the potential to be in frontline for not only pathogen detection during the epidemic outbreak, but also cancer, and genetic diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available